tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

MaxCyte reports preliminary Q3 revenue $6.8M, consensus $8.37M

Gross margin of $5.2 million in the third quarter of 2025. Non-GAAP adjusted gross margin of 81% excluding SPL Program-related revenue and reserves for excess and obsolete inventory. Total cash, cash equivalents and investments were $158.0 million as of September 30, 2025.

Meet Your ETF AI Analyst

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1